DEN230008 is an FDA 510(k) submission for the DermaSensor. This device is classified as a Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer (Class II - Special Controls, product code QZS).
Submitted by Dermasensor, Inc. (Miami, US). The FDA issued a Not Cleared (DENG) decision on January 12, 2024.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.1830. A Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer Is A Prescription Device That Uses A Software Algorithm To Analyze Optical Or Other Physical Properties Of A Skin Lesion And Returns A Classification Of The Skin Lesion. The Device Is Intended For Use By A Physician Not Trained In The Clinical Diagnosis And Management Of Skin Cancer As An Adjunctive Second-read Device Following Identification Of A Suspicious Skin Lesion. It Is Not For Use As A Standalone Diagnostic And Is Not For Use To Confirm A Clinical Diagnosis..